These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 11031849)
1. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination]. Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849 [TBL] [Abstract][Full Text] [Related]
2. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination]. Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392 [TBL] [Abstract][Full Text] [Related]
3. Meningococcal C vaccines: the Canadian experience. De Wals P Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070 [TBL] [Abstract][Full Text] [Related]
4. [Meningococcal disease in Spain, 1990-1997. Change in its epidemiological pattern]. de Mateo Ontañón S Rev Esp Salud Publica; 2000; 74(4):387-96. PubMed ID: 11031848 [TBL] [Abstract][Full Text] [Related]
5. [Meningococcal disease. The situation in Spain in the 1998-1999 period]. Cano Portero R; García Delgado C; de Mateo Ontañón S Rev Esp Salud Publica; 2000; 74(4):369-75. PubMed ID: 11031845 [TBL] [Abstract][Full Text] [Related]
6. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine. Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA; Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381 [TBL] [Abstract][Full Text] [Related]
7. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients]. de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525 [TBL] [Abstract][Full Text] [Related]
8. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave]. Arreaza L; de la Fuente L; Fernández S; Vázquez JA Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092 [TBL] [Abstract][Full Text] [Related]
9. [Results of a study on the under-detection of meningococcus in vaccinated subjects in Galicia]. Malvar Pintos A Rev Esp Salud Publica; 2000; 74(4):381-6. PubMed ID: 11031847 [TBL] [Abstract][Full Text] [Related]
10. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China. Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129 [TBL] [Abstract][Full Text] [Related]
11. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis. De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695 [TBL] [Abstract][Full Text] [Related]
12. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain. Larrauri A; Cano R; García M; Mateo Sd Vaccine; 2005 Jul; 23(32):4097-100. PubMed ID: 15908059 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and meningococcal serogroup distribution in the United States. Hershey JH; Hitchcock W Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868 [No Abstract] [Full Text] [Related]
14. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain). Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA; Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816 [TBL] [Abstract][Full Text] [Related]
15. Control of epidemic group A meningococcal disease in Auckland. Lennon D; Gellin B; Hood D; Leach DT; Woods GM; Williams P; Thakur S; Crombie D N Z Med J; 1993 Jan; 106(948):3-6. PubMed ID: 8423925 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic]. Krízová P; Vlcková J; Bobák M Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):9-14. PubMed ID: 7757351 [TBL] [Abstract][Full Text] [Related]
17. Neisseria meningitidis carriage during an outbreak of serogroup C disease. Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada. De Wals P; Deceuninck G; Lefebvre B; Boulianne N; De Serres G Pediatr Infect Dis J; 2011 Jul; 30(7):566-9. PubMed ID: 21326136 [TBL] [Abstract][Full Text] [Related]
19. Development of the epidemiological situation in invasive meningococcal disease in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Krízová P; Musílek M; Kalmusová J Cent Eur J Public Health; 1997 Dec; 5(4):214-8. PubMed ID: 9457424 [TBL] [Abstract][Full Text] [Related]
20. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37. Krizova P; Musilek M Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]